Universe Pharmaceuticals Inc
3 hedge funds and large institutions have $344K invested in Universe Pharmaceuticals Inc in 2024 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, reducing their positions, and 9 closing their positions.
104% more capital invested
Capital invested by funds: $168K → $344K (+$175K)
0.67% more ownership
Funds ownership: 0% → 0.67% (+0.67%)
67% less funds holding
Funds holding: 9 → 3 (-6)
67% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$967K |
| 2 |
AFM
Anson Funds Management
Dallas,
Texas
|
+$668K |
| 3 |
Morgan Stanley
New York
|
+$232 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$59.2K |
| 2 |
MML Investors Services
Springfield,
Massachusetts
|
-$57K |
| 3 |
TSS
Two Sigma Securities
New York
|
-$22.1K |
| 4 |
Renaissance Technologies
New York
|
-$9.58K |
| 5 |
QC
Quadrature Capital
London,
United Kingdom
|
-$6.06K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SM
1
Sabby Management
Miami Beach,
Florida
| $203K | +$967K | +8,334 | New |
|
|
AFM
2
Anson Funds Management
Dallas,
Texas
| $141K | +$668K | +5,760 | New |
|
|
3
Morgan Stanley
New York
| $40 | +$232 | +2 | New |
|
|
4
UBS Group
Zurich,
Switzerland
| – | -$59.2K | -404 | Closed |
|
|
5
MML Investors Services
Springfield,
Massachusetts
| – | -$57K | -390 | Closed |
|
|
TSS
6
Two Sigma Securities
New York
| – | -$22.1K | -151 | Closed |
|
|
7
Renaissance Technologies
New York
| – | -$9.58K | -65 | Closed |
|
|
QC
8
Quadrature Capital
London,
United Kingdom
| – | -$6.06K | -41 | Closed |
|
|
VF
9
Virtu Financial
New York
| – | -$4K | -28 | Closed |
|
|
SG
10
StoneX Group
New York
| – | -$3.66K | -25 | Closed |
|
|
XT
11
XTX Topco
George Town,
Cayman Islands
| – | -$3.62K | -25 | Closed |
|
12
Millennium Management
New York
| – | -$3.37K | -23 | Closed |
|
UPC Hedge Fund Activity: Q4 2024 in Review
3 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in Universe Pharmaceuticals Inc (UPC) for Q4 2024, worth a combined $344K — up 104% from $168K a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of UPC and 3 opened new positions — a net loss of 6 holders — while 0 trimmed existing stakes and 0 added.
The largest buyer was Sabby Management, opening a new position worth an estimated $967K. The largest seller was UBS Group, exiting entirely with an estimated $59.2K sold.
- 3 institutional investors held Universe Pharmaceuticals Inc (UPC) as of Q4 2024, down from 9 in Q3 2024.
- Funds reported $344K of Universe Pharmaceuticals Inc stock for Q4 2024, up 104% quarter-over-quarter.
- 3 funds opened new Universe Pharmaceuticals Inc positions in Q4 2024 and 9 closed out, a net change of -6 holders.
- The largest Universe Pharmaceuticals Inc buyer in Q4 2024 was Sabby Management, an estimated $967K added.
- The largest Universe Pharmaceuticals Inc seller in Q4 2024 was UBS Group, an estimated $59.2K sold.
Based on aggregated 13F filings for Q4 2024.